Bifogade filer
        
        
    
        
            
                Kurs
            
            
            
                -2,83%
            
            
        
    
    
    
                Kurs
            
            
            
                -2,83%
            
            
        Open
            50,00
        High
            50,00
        Low
            47,60
        Close
            48,00
        
            Kursutveckling under dagen för detta pressmeddelande
            (NOK).
        
    
            
            
    
            
                
                    Likviditet
                
            0,53 MNOK
        
    
    
    
                    Likviditet
                
            0,53 MNOK
        Rel. mcap
            0,06%
        Antal aktier
            10 659
        
            Likviditet under dagen för detta pressmeddelande
        
    Kalender
| Est. tid* | ||
| 2025-10-23 | - | Kvartalsrapport 2025-Q3 | 
| 2025-07-10 | - | Kvartalsrapport 2025-Q2 | 
| 2025-05-07 | - | X-dag ordinarie utdelning GENT 0.40 NOK | 
| 2025-05-07 | - | Kvartalsrapport 2025-Q1 | 
| 2025-05-06 | - | Årsstämma | 
| 2025-02-12 | - | Bokslutskommuniké 2024 | 
| 2024-10-31 | - | Kvartalsrapport 2024-Q3 | 
| 2024-08-29 | - | Kvartalsrapport 2024-Q2 | 
| 2024-04-30 | - | X-dag ordinarie utdelning GENT 0.00 NOK | 
| 2024-04-30 | - | Kvartalsrapport 2024-Q1 | 
| 2024-04-29 | - | Årsstämma | 
| 2024-02-09 | - | Bokslutskommuniké 2023 | 
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 | 
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 | 
| 2023-05-05 | - | X-dag ordinarie utdelning GENT 0.00 NOK | 
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 | 
| 2023-05-04 | - | Årsstämma | 
| 2023-02-16 | - | Bokslutskommuniké 2022 | 
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 | 
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 | 
| 2022-05-19 | - | X-dag ordinarie utdelning GENT 0.00 NOK | 
| 2022-05-18 | - | Årsstämma | 
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 | 
| 2022-02-17 | - | Bokslutskommuniké 2021 | 
| 2021-10-21 | - | Kvartalsrapport 2021-Q3 | 
| 2021-08-25 | - | Kvartalsrapport 2021-Q2 | 
| 2021-05-05 | - | X-dag ordinarie utdelning GENT 0.00 NOK | 
| 2021-05-04 | - | Årsstämma | 
| 2021-04-16 | - | Kvartalsrapport 2021-Q1 | 
| 2021-02-11 | - | Bokslutskommuniké 2020 | 
| 2020-10-29 | - | Kvartalsrapport 2020-Q3 | 
| 2020-08-21 | - | Kvartalsrapport 2020-Q2 | 
| 2020-05-15 | - | X-dag ordinarie utdelning GENT 0.00 NOK | 
| 2020-05-14 | - | Årsstämma | 
| 2020-04-24 | - | Kvartalsrapport 2020-Q1 | 
| 2020-02-14 | - | Bokslutskommuniké 2019 | 
| 2019-11-21 | - | Extra Bolagsstämma 2019 | 
| 2019-05-10 | - | X-dag ordinarie utdelning GENT 0.00 NOK | 
| 2018-07-13 | - | Extra Bolagsstämma 2018 | 
| 2018-06-13 | - | X-dag ordinarie utdelning GENT 0.00 NOK | 
| 2018-02-27 | - | Bokslutskommuniké 2017 | 
| 2017-06-06 | - | Årsstämma | 
Beskrivning
| Land | Norge | 
|---|---|
| Lista | Oslo Bors | 
| Sektor | Hälsovård | 
| Industri | Bioteknik | 
      2025-03-03 10:29:57
Moss, 3 March 2025
Gentian Diagnostics ASA ("Gentian") has today been notified that the following
transaction has been completed by a close associate of a primary insider in
Gentian:
Holta Invest AS, a close associate of Espen Tidemann Jørgensen, a board member
and primary insider in Gentian, has sold 1,228,502 shares in Gentian at NOK
46.50 per share.
PCA notification pursuant to the EU Market Abuse Regulation Article 19 is
attached.
This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article
19 and Euronext Oslo Rule Book II.
For further information, please contact: Njaal Kind, Group CFO,
njaal.kind@gentian.no, +47 91 90 65 25
 
                 
                 
             
             PCA - Holta Invest AS
                
                PCA - Holta Invest AS